Support is requested for continuation of a postdoctoral training program in emerging infectious diseases and biodefense that would support 6 trainees annually and prepare them for clinical, epidemiological, applied or basic research careers in this field. Training will be provided by 21 Program Faculty and 15 Associate Program Faculty in the departments of Pathology, Internal Medicine, Microbiology and Immunology, Pediatrics, Biochemistry and Molecular Biology and Preventive Medicine and Community Health at the University of Texas Medical Branch (UTMB). Faculty include a number ot former trainees. Other resources available at UTMB for the training program include the Center for Biodefense and Emerging Infectious Diseases, the Western Regional Center for Biodefense and Emerging Infectious Diseases, the Institute for Human Infections and Immunity, the Center for Hepatitis Research, the Sealy Center for Vaccine Development, the Keck Center for Virus Imaging, the Sealy Center for Structural Biology, the Galveston National Laboratory, the WHO/PAHO Collaborating Center for Tropical Diseases, and the Galveston Global Health Consortium. There is currently a shortage of trained research scientists with the knowledge and experience necessary to work with emerging infectious disease agents or NIAID category A, B, and C priority pathogens. UTMB now has a critical mass of outstanding faculty and support personnel working the this area, including state-of-the-art containment facilities needed to work with highly pathogenic organisms. The program's goal is leverage the rich and vibrant research environment at UTMB to enable trainees to become independent investigators within the broad field of emerging infectious diseases and biodefense.
Emerging infections and biodefense are important areas of research and there are not enough trained investigators in these fields. This grant will address this shortage by training outstanding.investigators in a dynamic training environment.
|Roy, Chad J; Adams, A Paige; Wang, Eryu et al. (2014) Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. J Infect Dis 209:1891-9|
|Dunphy, Paige Selvy; Luo, Tian; McBride, Jere W (2014) Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival. Infect Immun 82:4154-68|
|Santiago, Felix W; Covaleda, Lina M; Sanchez-Aparicio, Maria T et al. (2014) Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol 88:4572-85|
|Felices, Vidal; Ampuero, Julia S; Guevara, Carolina et al. (2014) St. Louis encephalitis virus infection in woman, Peru. Emerg Infect Dis 20:730-2|
|Endsley, Mark A; Somasunderam, Anoma D; Li, Guangyu et al. (2014) Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain. Virology 454-455:60-6|
|Roy, Chad J; Adams, A Paige; Wang, Eryu et al. (2013) A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus. Vaccine 31:1464-70|
|Guerbois, Mathilde; Volkova, Eugenia; Forrester, Naomi L et al. (2013) IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety. PLoS Negl Trop Dis 7:e2197|
|Rossi, Shannan L; Guerbois, Mathilde; Gorchakov, Rodion et al. (2013) IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice. Virology 437:81-8|
|Gorchakov, Rodion; Wang, Eryu; Leal, Grace et al. (2012) Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol 86:6084-96|
|Rossi, S L; Nasar, F; Cardosa, J et al. (2012) Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology 423:58-67|
Showing the most recent 10 out of 72 publications